The Hospital for Sick Children (SickKids) and University of Toronto, Toronto, Ontario, Canada.
The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada.
Arthritis Rheumatol. 2022 Aug;74(8):1409-1419. doi: 10.1002/art.42113. Epub 2022 Jun 28.
The aim of the Paediatric Rheumatology International Trials Organisation (PRINTO) juvenile idiopathic arthritis (JIA) classification criteria, which is still in development, is to identify homogeneous groups of JIA patients. This study was undertaken to compare International League of Associations for Rheumatology (ILAR) JIA classification criteria and PRINTO JIA classification criteria using data from the ReACCh-Out (Research in Arthritis in Canadian Children, Emphasizing Outcomes) cohort.
We used clinicobiologic data recorded within 7 months of diagnosis to assign a diagnosis of JIA and identify subcategories of JIA among 1,228 patients according to the 2 JIA classification systems. We compared the proportions of patients classified and the alignment of classification categories with clinicobiologic subtypes and adult arthritis types.
The PRINTO criteria classified 244 patients (19.9%) as having early-onset antinuclear antibody-positive JIA, 157 (12.8%) as having enthesitis/spondylitis-related JIA, 38 (3.1%) as having systemic JIA, and 10 (0.8%) as having rheumatoid factor-positive JIA. A total of 12% of patients were unclassifiable using the ILAR criteria, while 63.3% were unclassifiable using the PRINTO criteria (777 with other JIA and 2 with unclassified JIA). In sensitivity analyses, >50% of patients remained unclassifiable using the PRINTO criteria. Compared to the PRINTO criteria, ILAR JIA categories aligned better with clinicobiologic subtypes in 131 patients (χ = 44, P = 0.005, versus χ = 15, P = 0.07 for PRINTO), and ILAR categories aligned better with adult types of arthritis in 389 evaluable patients.
Currently identified PRINTO disorders can only be used to classify a minority of JIA patients, leaving a large proportion of JIA patients with other disorders requiring further characterization. Current PRINTO JIA classification criteria do not align better with clinicobiologic subtypes or adult forms of arthritis compared with the older ILAR classification system.
儿科风湿病国际试验组织(PRINTO)幼年特发性关节炎(JIA)分类标准仍在制定中,旨在确定 JIA 患者的同质组。本研究旨在使用 ReACCh-Out(加拿大儿童关节炎研究,强调结局)队列的数据比较国际风湿病联盟(ILAR)JIA 分类标准和 PRINTO JIA 分类标准。
我们使用诊断后 7 个月内记录的临床生物学数据,根据 2 种 JIA 分类系统,将 1228 例患者诊断为 JIA,并确定 JIA 的亚类。我们比较了两种分类系统分类的患者比例以及分类类别与临床生物学亚型和成人关节炎类型的一致性。
PRINTO 标准将 244 例患者(19.9%)归类为早发性抗核抗体阳性 JIA,157 例(12.8%)归类为附着点炎/脊柱关节炎相关 JIA,38 例(3.1%)归类为全身 JIA,10 例(0.8%)归类为类风湿因子阳性 JIA。使用 ILAR 标准,12%的患者无法分类,而使用 PRINTO 标准,63.3%的患者无法分类(777 例为其他 JIA,2 例为未分类 JIA)。在敏感性分析中,使用 PRINTO 标准,仍有超过 50%的患者无法分类。与 PRINTO 标准相比,ILAR JIA 类别在 131 例患者中与临床生物学亚型更一致(χ=44,P=0.005,而 PRINTO 为 χ=15,P=0.07),在 389 例可评估患者中,ILAR 类别与成人关节炎类型更一致。
目前确定的 PRINTO 疾病只能用于分类少数 JIA 患者,留下大量其他疾病的 JIA 患者需要进一步描述。与较旧的 ILAR 分类系统相比,目前的 PRINTO JIA 分类标准与临床生物学亚型或成人形式的关节炎的一致性较差。